Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study

Further Publications NeurologyFurther Publications Psychiatry

Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial

Lancet Gastroenterol Hepatol.

Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, Whorwell PJ, de Wit NJ

doi: 10.1016/S2468-

Bipolar Disorder

A meta-analysis and systematic review of the comorbidity between irritable bowel syndrome and bipolar disorder

Medicine (Baltimore).

Tseng PT, Zeng BS, Chen YW, Wu MK, Wu CK, Lin PY

doi: 10.1097/

Further Publications Psychiatry

Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials

Lancet Gastroenterol Hepatol

Staudacher HM, Mikocka-Walus A, Ford AC

doi: 10.1016/S2468-1253(20)30363-0

Anxiety and Depression

Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study

Lancet Psychiatry.

Agger JL, Schröder A, Gormsen LK, Jensen JS, Jensen TS, Fink PK

doi: 10.1016/

Multiple Sclerosis

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study

Lancet Neurol.

Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA

doi: 10.1016/

Parkinson’s DiseaseAnxiety and Depression

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study

Lancet Neurol.

Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, Alonso-Frech F, Foffani G, Obeso I, Gasca-Salas C, de Luis-Pastor E, Vela L, Obeso JA

doi: 10.1016/

Anxiety and Depression

Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study

J Clin Psychiatry.

Fava M, Ménard F, Davidsen CK, Baker RA

doi: 10.4088/JCP.15m10470.

Aging and Cognitive FunctionsBipolar Disorder

Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study

Lancet Psychiatry.

Yatham LN, Mackala S, Basivireddy J, Ahn S, Walji N, Hu C, Lam RW, Torres IJ

doi: 10.1016/

Guillain-Barré syndrome subtype diagnosis: A prospective multicentric European study

Muscle Nerve.

Van den Bergh PYK, Piéret F, Woodard JL, Attarian S, Grapperon AM, Nicolas G, Brisset M, Cassereau J, Rajabally YA, Van Parijs V, Verougstraete D, Jacquerye P, Raymackers JM, Redant C, Michel C, Delmont E; University of Louvain GBS Electrodiagnosis Study Group

doi: 10.1002/mus.26056.

Related content

Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial

A meta-analysis and systematic review of the comorbidity between irritable bowel syndrome and bipolar disorder

Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials

Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study

Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study

Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study

Guillain-Barré syndrome subtype diagnosis: A prospective multicentric European study